PUBLISHER: Allied Market Research | PRODUCT CODE: 1193134
PUBLISHER: Allied Market Research | PRODUCT CODE: 1193134
Menstrual cramps are strong cramping pains in lower abdomen. Many women experience menstrual pains shortly before and throughout their periods. It can be caused by conditions such as endometriosis or uterine fibroids. Symptoms of menstrual cramps include throbbing or cramping pain in the lower abdomen, and pain in lower back and thighs. Some women also experience nausea, loose stools, headache, and dizziness.
The growth of global menstrual cramps treatment market is majorly driven by increase in demand for menstrual cramps treatment, owing to rise in cases of menstrual pain in women. In addition, growing awareness of menstrual cramps treatment further drive growth of the menstrual cramps treatment market. However, lack of knowledge regarding menstrual cramps treatment and side effects of menstrual cramps drugs such as nausea, constipation and vomiting hinders the market growth. Conversely, growth opportunities in emerging markets and surge in expenditure worldwide are anticipated to provide lucrative opportunities to the market players.
The menstrual cramps treatment market is segmented into type, treatment, distribution channel, and region. On the basis of type, the market is categorized into primary dysmenorrhea and secondary dysmenorrhea. On the basis of treatment, the market is segregated into non-steroidal anti-inflammatory drugs and hormonal therapy. On the basis of distribution channel, the market is classified into hospital pharmacies and drug stores & retail pharmacies and online providers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global menstrual cramps treatment market are Abbott Laboratories, AbbVie Inc., Bayer AG, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Limited, and Torrent Pharmaceuticals.
Key Benefits For Stakeholders
By Type
By Treatment
By Distribution Channel
By Region